For instance, stem cell treatment demonstrates apparent beneficial effects in preclinical stroke models by reducing infarct size and improving behavioral and histological deficits [42] by secreting the growth-promoting factors glial cell line-derived neurotrophic factor (GDNF) and brain-derived neurotrophic factor (BDNF). The gene discussed is BDNF; the disease is Stroke.